DMEPOS competitive bid program delayed
This article was originally published in The Gray Sheet
Executive Summary
CMS finalizes a delay of its Medicare competitive bidding program for durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) until April 18, 2009, after receiving approximately 550 comments between Feb. 10 and Feb. 13 - all in favor of a delay - according to a Feb. 19 Federal Register notice ("1The Gray Sheet" Feb. 16, 2009, p. 19). CMS says it appreciates commenters' concerns about the program, is reviewing issues of law and policy surrounding it, and will allow the public until March 17 to submit comments "on the substantive policy issues" that the DMEPOS competitive bidding program raises
You may also be interested in...
CMS Weighs Changes To Competitive Bidding Program
CMS would use a proposed further delay in its competitive bidding program for durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) to review "issues of law and policy," the agency says in a Feb. 10 Federal Register notice
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.